Adtalem Global Education (NYSE:CVSA) CFO Sells $326,831.46 in Stock

Adtalem Global Education Inc. (NYSE:CVSA) CFO Robert Phelan sold 2,414 shares of the company’s stock in a transaction dated Wednesday, July 8th. The shares were sold at an average price of $135.39, for a total transaction of $326,831.46. Following the completion of the transaction, the chief financial officer directly owned 50,492 shares of the company’s stock, valued at approximately $6,836,111.88. The trade was a 4.56% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Adtalem Global Education Stock Performance

Shares of NYSE:CVSA traded down $0.68 during trading on Friday, hitting $130.64. The company’s stock had a trading volume of 301,004 shares, compared to its average volume of 347,922. The company has a quick ratio of 0.70, a current ratio of 0.70 and a debt-to-equity ratio of 0.36. Adtalem Global Education Inc. has a fifty-two week low of $86.97 and a fifty-two week high of $156.26. The firm’s 50-day simple moving average is $124.72. The stock has a market capitalization of $4.45 billion, a P/E ratio of 20.35, a PEG ratio of 0.99 and a beta of 0.62.

Adtalem Global Education (NYSE:CVSA) last posted its quarterly earnings data on Thursday, May 7th. The company reported $1.98 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.73 by $0.25. The company had revenue of $487.03 million for the quarter. Adtalem Global Education had a return on equity of 20.19% and a net margin of 12.26%.Adtalem Global Education’s revenue for the quarter was up 4.5% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.92 earnings per share. Adtalem Global Education has set its FY 2026 guidance at 7.950-8.150 EPS. On average, equities analysts predict that Adtalem Global Education Inc. will post 8.04 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of research firms recently commented on CVSA. Zacks Research downgraded Adtalem Global Education from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, March 25th. Truist Financial upped their price target on Adtalem Global Education from $130.00 to $140.00 and gave the company a “buy” rating in a research report on Monday, May 11th. Barrington Research reiterated an “outperform” rating and set a $170.00 target price on shares of Adtalem Global Education in a research note on Monday, June 8th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Adtalem Global Education in a report on Friday, May 22nd. Finally, Wall Street Zen upgraded Adtalem Global Education from a “hold” rating to a “buy” rating in a research note on Saturday, June 13th. Two equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $155.00.

About Adtalem Global Education

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.